These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 688536)

  • 21. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
    Kitamura J; Mori H; Sugie S; Kawai K
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of cadralazine in human whole blood using reversed-phase high-performance liquid chromatography: utilizing a salting-out extraction procedure.
    Rustum AM
    J Chromatogr; 1989 Apr; 489(2):345-52. PubMed ID: 2753958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.
    Garcia-Martínez S; Rico E; Casal E; Grisaleña A; Alcaraz E; King N; Leal N; Navarro I; Campanero MÁ
    J Pharm Biomed Anal; 2018 Feb; 150():427-435. PubMed ID: 29289894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of chlordiazepoxide (librium) and of a metabolite of lactam character in plasma of humans, dogs, and rats by a specific spectrofluorometric micro method.
    KOECHLIN BA; D'ARCONTE L
    Anal Biochem; 1963 Mar; 5():195-207. PubMed ID: 14034091
    [No Abstract]   [Full Text] [Related]  

  • 25. Gas chromatographic determination of diftalone in human plasma by use of an automatic sampler.
    Morrone A; Beretta E
    J Chromatogr; 1976 Nov; 128(1):27-33. PubMed ID: 993302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance liquid chromatographic separation of cadralazine from its potential metabolites and degradation products. Quantitation of the drug in human plasma and urine.
    Crolla T; Santini F; Visconti M; Pifferi G
    J Chromatogr; 1984 Sep; 310(1):139-49. PubMed ID: 6501510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of the enantiomers of pimobendan and its main metabolite in rat plasma by high-performance liquid chromatography.
    Asakura M; Nagakura A; Tarui S; Matsumura R
    J Chromatogr; 1993 Apr; 614(1):135-41. PubMed ID: 8496273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 29. High-performance liquid chromatographic determination of cadralazine in human plasma and urine.
    Emilsson H
    J Chromatogr; 1988 Jan; 424(1):119-28. PubMed ID: 3366823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-atherosclerotic and antihypertensive agents (XI)].
    Eguchi Y; Sugimoto A; Ito S; Nakajima M; Kaneko S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1984; 18():17-23. PubMed ID: 6598493
    [No Abstract]   [Full Text] [Related]  

  • 31. A sensitive high performance liquid chromatography microassay for bemoradan, a novel cardiotonic agent, in plasma/serum using a semi-automatic liquid/solid extraction sample preparation system--AASP.
    Huang SM; Chien SC; Flor SC
    Biomed Chromatogr; 1990 Mar; 4(2):52-5. PubMed ID: 2350597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
    Orallo F; Calleja JM; García Mera G; Raviña E
    Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative determination of tiamenidine hydrochloride in human serum using gas chromatography mass spectrometry.
    Fehlhaber HW; Metternich K; Tripier D; Uihlein M
    Biomed Mass Spectrom; 1978 Mar; 5(3):188-91. PubMed ID: 630059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tetrahydrodipyranophthalazines and tetrahydrodipyranobenzoxazines (author's transl)].
    Eiden F; Schmiz C
    Arch Pharm (Weinheim); 1976 Oct; 309(10):798-803. PubMed ID: 1008676
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and pharmacological study of 4,4a,5,6-tetrahydro-4a-substituted-benzo(h)cinnolin-3(2H)ones.
    Barlocco D; Pinna GA; Carboni L; Cipolla P
    Farmaco; 1989 Oct; 44(10):967-74. PubMed ID: 2619862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Communications to the editor: Metabolites of DJ-1461 in rat urine.
    Sano M; Moroi R; Ono K
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):3006-9. PubMed ID: 4468119
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of 1-(1,4,5,6-tetrahydro-1,2,4-triazinyl)phthalazine derivatives possessing antihypertensive properties.
    Kolwas J
    Acta Pol Pharm; 1984; 41(4):405-10. PubMed ID: 6532132
    [No Abstract]   [Full Text] [Related]  

  • 38. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
    Demirayak S; Karaburun AC; Beis R
    Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective determination of 1-[4-(2-methoxyethyl)phenoxy]-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanol hydrochloride, a novel antihypertensive agent, in rat plasma and tissues by liquid chromatography-tandem mass spectrometry.
    He S; Wu S; Zhu W; Guan Y; Li G; Si L; Huang J
    J Sep Sci; 2017 Nov; 40(21):4135-4141. PubMed ID: 28845584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
    Yasunaga K
    Rinsho Byori; 1979; Suppl 40():181-7. PubMed ID: 551223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.